Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 5510

Sort by

Sort Order Select

Journal Articles

Adult thymectomy is associated with increased mortality risk from cancer but not cardiovascular disease

Kameron A. Kooshesh, Brody H. Foy, Richard A. Baylis, Karin Gustafsson, Daniel A. Zlotoff, Tomas G. Neilan, David T. Scadden

Blood Adv (2025) 9 (21): 5449–5452.

https://doi.org/10.1182/bloodadvances.2024015286

Published: 2025

Includes: Supplemental data

Journal Articles

Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy

Blood Adv (2025) 9 (21): 5616–5625.

https://doi.org/10.1182/bloodadvances.2025016298

Published: 2025

Journal Articles

KDIGO-defined kidney dysfunction predicts long-term outcomes in a multicenter cohort of adults with sickle cell disease

Xu Zhang, Michael R. DeBaun, Kristin Wuichet, Rima Zahr, Zalaya Ivy, Mitchell J. Weiss, Alex G. Bick, Victor R. Gordeuk, Santosh L. Saraf

Blood Adv (2025) 9 (21): 5610–5615.

https://doi.org/10.1182/bloodadvances.2025017204

Published: 2025

Includes: Supplemental data

Journal Articles

Phosphorylation at Y317 on Syk negatively regulates both ITAM- and hemITAM-mediated signaling and function in platelets

Manal A. Elzoheiry, Carol A. Dangelmaier, Dhruv N. Vajipayajula, Monica N. Wright, Alexander Y. Tsygankov, Satya P. Kunapuli

Blood Adv (2025) 9 (21): 5626–5637.

https://doi.org/10.1182/bloodadvances.2025016714

Published: 2025

Includes: Supplemental data

Journal Articles

Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms in blastic phase

Blood Adv (2025) 9 (21): 5598–5609.

https://doi.org/10.1182/bloodadvances.2025016898

Published: 2025

Includes: Supplemental data

Journal Articles

Vaccine-educated T cells and a CD123 bispecific T-cell engager for treatment of acute myeloid leukemia

Blood Adv (2025) 9 (21): 5585–5597.

https://doi.org/10.1182/bloodadvances.2024015449

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of radiotherapy site, modality, and dose on subsequent clonal hematopoiesis

Alexander G. Goglia, Griffen R. Mustion, Leslie A. Modlin, Ross L. Levine, Kelly L. Bolton, Lior Z. Braunstein

Blood Adv (2025) 9 (21): 5564–5567.

https://doi.org/10.1182/bloodadvances.2025016376

Published: 2025

Includes: Supplemental data

Journal Articles

Next-generation flow cytometry analysis of clonal bone marrow plasma cells identifies an indolent subset of MGUS

Jón Þórir Óskarsson, Sigrun Thorsteinsdottir, Sæmundur Rögnvaldsson, Andri Ólafsson, Gunnhildur Viðarsdóttir, Elfa Rún Guðmundsdóttir, Elias Eythorsson, Ásbjörn Jónsson, Brynjar Viðarsson, Páll T. Önundarson, Bjarni A. Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Stephen J. Harding, Brian GM Durie, Thorvardur Jon Love, Sigurdur Y. Kristinsson

Blood Adv (2025) 9 (21): 5455–5459.

https://doi.org/10.1182/bloodadvances.2025017270

Published: 2025

Journal Articles

Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR

Blood Adv (2025) 9 (21): 5460–5472.

https://doi.org/10.1182/bloodadvances.2025016141

Published: 2025

Includes: Supplemental data

Journal Articles

Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study

Blood Adv (2025) 9 (21): 5399–5408.

https://doi.org/10.1182/bloodadvances.2025016546

Published: 2025

Journal Articles

Efficacy and safety of thrombolysis for pediatric venous thromboembolism: a systematic review and meta-analysis

Blood Adv (2025) 9 (21): 5512–5527.

https://doi.org/10.1182/bloodadvances.2025017058

Published: 2025

Includes: Supplemental data

Journal Articles

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study

Blood Adv (2025) 9 (21): 5409–5422.

https://doi.org/10.1182/bloodadvances.2025016651

Published: 2025

Includes: Supplemental data

Journal Articles

Novel devimistat results in complete remissions in heavily pretreated Burkitt lymphoma in a phase 2 trial

Raphael Steiner, Liana Nikolaenko, Ranjit Nair, Venkatraman Seshan, Swetha Kambhampati Thiruvengadam, Niloufer Khan, Jeremy S. Abramson, Steven Horwitz, Matthew Matasar, Colette Owens, Ildefonso Ismael Rodriguez Rivera, David J. Straus, Timothy S. Pardee, Sanjeev Luther, Sabrina Saboukoulou, Win Su Thet, Shreya Vemuri, Ariela Noy

Blood Adv (2025) 9 (21): 5556–5563.

https://doi.org/10.1182/bloodadvances.2025016168

Published: 2025

Includes: Supplemental data

Journal Articles

A disrupted adenosinergic axis facilitates platelet activation in APS: exploring a novel therapeutic target

Somanathapura K. NaveenKumar, Thalia G. Newman, Bruna Mazetto Fonseca, Srilakshmi Yalavarthi, Mariane C. Flores Nascimento, Kaitlyn Sabb, Katarina Kmetova, Emily Chong, Kavya Sugur, Caroline H. Ranger, Megan P. Tompkins, Cyrus Sarosh, Jacqueline A. Madison, Ajay Tambralli, Jordan K. Schaefer, Michael Holinstat, Yu Zuo, Jason S. Knight

Blood Adv (2025) 9 (21): 5423–5435.

https://doi.org/10.1182/bloodadvances.2025016162

Published: 2025

Includes: Supplemental data

Journal Articles

Measurable residual disease detection after CAR-T may predict response in patients with large B-cell lymphoma

Blood Adv (2025) 9 (21): 5539–5545.

https://doi.org/10.1182/bloodadvances.2024015788

Published: 2025

Includes: Supplemental data

Journal Articles

HLA-E [pHLA-G] complex–specific monoclonal antibody enhancing NK activity in multiple myeloma

Muhammad Abu Ahmad, Olga Radinsky, Bar Kaufman, Kamran Waidha, Eman Gharra, Sharon Dim, Dinesh Babu Manikandan, Noa Ofir, Dirk Jäger, Marten Meyer, Moshe Elkabets, Kerry S. Campbell, Miri Zektser, Roi Gazit, Ory Rouvio, Frank Momburg, Angel Porgador

Blood Adv (2025) 9 (21): 5436–5448.

https://doi.org/10.1182/bloodadvances.2025016276

Published: 2025

Includes: Supplemental data

Journal Articles

Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis

Blood Adv (2025) 9 (21): 5489–5500.

https://doi.org/10.1182/bloodadvances.2025016149

Published: 2025

Includes: Supplemental data

Journal Articles

Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGVHD biomarkers

Teresa Caballero-Velázquez, Javier Delgado Serrano, Lucía López-Corral, Christelle Ferra-Coll, Clara Beatriz García-Calderón, David Valcárcel, Irene García-Cadenas, Estefanía Pérez López, María-José Jiménez Lorenzo, Francisco Manuel Martín-Domínguez, María de los Reyes Jiménez-León, Guillermo Orti, Virginia Escamilla Gómez, Cristina Blázquez-Goñi, Almudena Cabero Martínez, Henry Andrade Ruiz, Estefanía Menéndez-Pedregal, Fermín Sánchez-Guijo, José Antonio Pérez Simón

Blood Adv (2025) 9 (21): 5528–5538.

https://doi.org/10.1182/bloodadvances.2025016284

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes of patients with suspected heparin-induced thrombocytopenia in a contemporary multicenter cohort

Henning Nilius, Ekaterina Sinitsa, Jan-Dirk Studt, Dimitrios A. Tsakiris, Andreas Greinacher, Adriana Mendez, Adrian Schmidt, Walter A. Wuillemin, Bernhard Gerber, Prakash Vishnu, Lukas Graf, Johanna A. Kremer Hovinga, Tamam Bakchoul, Michael Nagler

Blood Adv (2025) 9 (21): 5546–5555.

https://doi.org/10.1182/bloodadvances.2025016639

Published: 2025

Includes: Supplemental data

Journal Articles

Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study

Eugenio Galli, Roberta Di Blasi, Alice Di Rocco, Caterina Cristinelli, Ilaria Pansini, Côme Bommier, Alessandro Corrente, Ilenia De Bernardis, Marcello Viscovo, Stefan Hohaus, Anna Modoni, Federica Sorà, Patrizia Chiusolo, Maurizio Martelli, Simona Sica, Catherine Thieblemont

Blood Adv (2025) 9 (21): 5501–5509.

https://doi.org/10.1182/bloodadvances.2025017378

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Adult thymectomy is associated with increased mortality risk from cancer but not cardiovascular disease

Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy

KDIGO-defined kidney dysfunction predicts long-term outcomes in a multicenter cohort of adults with sickle cell disease

Phosphorylation at Y317 on Syk negatively regulates both ITAM- and hemITAM-mediated signaling and function in platelets

Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms in blastic phase

Vaccine-educated T cells and a CD123 bispecific T-cell engager for treatment of acute myeloid leukemia

Impact of radiotherapy site, modality, and dose on subsequent clonal hematopoiesis

Next-generation flow cytometry analysis of clonal bone marrow plasma cells identifies an indolent subset of MGUS

Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR

Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study

Efficacy and safety of thrombolysis for pediatric venous thromboembolism: a systematic review and meta-analysis

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study

Novel devimistat results in complete remissions in heavily pretreated Burkitt lymphoma in a phase 2 trial

A disrupted adenosinergic axis facilitates platelet activation in APS: exploring a novel therapeutic target

Measurable residual disease detection after CAR-T may predict response in patients with large B-cell lymphoma

HLA-E [pHLA-G] complex–specific monoclonal antibody enhancing NK activity in multiple myeloma

Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis

Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGVHD biomarkers

Outcomes of patients with suspected heparin-induced thrombocytopenia in a contemporary multicenter cohort

Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only